Alternative drug sensitivity metrics improve preclinical cancer pharmacogenomics.
about
GRcalculator: an online tool for calculating and mining dose-response data.Common and cell-type specific responses to anti-cancer drugs revealed by high throughput transcript profiling.The Library of Integrated Network-Based Cellular Signatures NIH Program: System-Level Cataloging of Human Cells Response to Perturbations.Quantification of sensitivity and resistance of breast cancer cell lines to anti-cancer drugs using GR metrics.PharmacoDB: an integrative database for mining in vitro anticancer drug screening studies.Chemistry-First Approach for Nomination of Personalized Treatment in Lung Cancer.Improved Dose-Response Relationship of (+)-Discodermolide-Taxol Hybrid Congeners.
P2860
Q42634575-948C199A-BC15-42CF-8941-A2F82D2F8ACFQ43635406-4F033A44-6A0D-4E53-BDAC-F2DAA63651EBQ46954616-B0519B49-DD09-4E44-9861-A938929808B5Q47111961-342B9C82-6BB7-4EE7-B16C-DF756E5800C8Q47134581-A78FD78D-BBDD-403A-84A4-0A5259E9F9D3Q52313314-965827E0-95B5-4F67-A767-EF2D3D4BAB9BQ55417605-937A5F41-27E6-47EA-80B2-90E70B4C27E1
P2860
Alternative drug sensitivity metrics improve preclinical cancer pharmacogenomics.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Alternative drug sensitivity metrics improve preclinical cancer pharmacogenomics.
@en
Alternative drug sensitivity metrics improve preclinical cancer pharmacogenomics.
@nl
type
label
Alternative drug sensitivity metrics improve preclinical cancer pharmacogenomics.
@en
Alternative drug sensitivity metrics improve preclinical cancer pharmacogenomics.
@nl
prefLabel
Alternative drug sensitivity metrics improve preclinical cancer pharmacogenomics.
@en
Alternative drug sensitivity metrics improve preclinical cancer pharmacogenomics.
@nl
P2860
P50
P356
P1433
P1476
Alternative drug sensitivity metrics improve preclinical cancer pharmacogenomics.
@en
P2860
P2888
P304
P356
10.1038/NBT.3882
P577
2017-06-01T00:00:00Z
P6179
1085912146